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INTRODUCTION
Modern osseointegrated bone conduction hearing systems, such 
as Baha
®, are fitted based on the patient’s audiometric hearing 
thresholds. However, an important limitation when measuring a 
patient’s bone conduction thresholds using an audiometer is that 
the transmission of vibrations must pass through the skin to the 
cochlea in the temporal bone. Furthermore, in the case of single-
sided sensorineural deafness (SSD), the sound must continue 
through the temporal bone to the contralateral cochlea with ap-
proximately 5-10 dB further interaural attenuation (1-3). Of 
concern is that the variability between or within patients is be-
tween 0-30 dB at any given frequency (1). This attenuation of 
sound through the skin and bone adds to the variability in a 
Baha fitting and if not accounted for may lead to the patient be-
ing under- or over-amplified. Potentially, this could result in poor-
er than predicted performance with the Baha sound processor 
(2, 4-7). Therefore, if we wish to increase the accuracy of the ini-
tial fitting, clinicians require a mechanism to easily and directly 
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measure the bone conduction thresholds in an individual patient.
  A proposed solution is to generate test signals from the Baha 
sound processor and transmit these directly to the cochlea via 
an osseointegrated implant. This test condition has been labeled 
direct bone conduction (DBC) (8). 
  In terms of developing a clinical application, Stenfelt and 
Hakansson (4) proposed three measures that could be used to 
measure the direct bone conduction in a patient. The first is to 
measure the force or acceleration required. While this is advan-
tageous because it is independent of the transducer, this type of 
measurement is difficult to perform clinically. The second is to 
measure the patient’s free-field hearing thresholds. This would 
involve measurement of the entire Baha system, thereby increas-
ing the variability, and it could be confounded by the impact of 
non-linear signal processing such as expansion and compression. 
Third is to directly measure the voltage driving the transducer. In 
this case, the desired voltage can be converted to force thresh-
olds and a corresponding levels in dB HL. 
  Similar to the third proposal, the authors developed a proce-
dure applicable to the clinical setting. Here, an inbuilt digital sig-
nal generator in the Baha device can be used to measure the pa-
tient’s thresholds. The digital values required to produce the 
threshold can then be recorded by a connection to a computer 
using a standard interface used by hearing aids, i.e., Hi-Pro, Noah 
Link, or similar (9). The key advantage of this method is that all 
tolerance chains normally experienced between measurement 
equipment and device setups are eliminated.
  The aim of the present investigation is two-fold. The first is to 
validate, with a new Baha sound processor, the previously pub-
lished reference equivalent threshold force level for DBC (10). 
The second is to determine the clinical need for measuring DBC 
values through a Baha sound processor.
MATERIALS AND METHODS
Subjects
Twenty adults with a skin penetrating titanium implant for stan-
dard attachment of a Baha participated in this study (Table 1). 
The subjects were patients with conductive or mixed hearing 
loss. Each subject was selected for the Baha procedure in line 
with internationally accepted patient selection criteria (11). The 
study was conducted following good clinical practice (GCP) with 
approval from the Regional Ethical Review Board in Gothenburg.
Materials
The test device used was the Cochlear Baha BP100 (Cochlear 
Bone Anchored Solutions AB, Gothenburg, Sweden) sound pro-
cessor in combination with the Cochlear Baha Fitting Software 
ver. 1.0. The combination allows the use of a software feature 
called BC Direct to measure direct bone conduction. The patient’s 
responses to the vibratory signals by the Baha sound processor 
are obtained (Fig. 1). The Fitting Software allows the frequency 
(Hz) and level (dB HL) of those sounds to be controlled.
  The device signal generator and connected computer system 
were calibrated so that, for a given frequency, a dB HL value 
read in the Cochlear Baha Fitting Software ver. 1.0 would cor-
respond to the device force level outputs suggested by Carlsson 
et al. (10). As audiologists are most familiar with the dB HL 
method of measurement, the scale provided is in dB HL.
  The maximum output force value of the device is measured 




Gender Age Baha side
BC PTA
Masked Unmasked
1 Female 62 Right 17.5 13.75
2 Male 59 Left 21.25 18.75
3 Female 69 Left 43.75 27.5
4 Male 31 Right 16.25 13.75
5 Male 64 Right 36.25 23.75
6 Female 65 Left 23.75 18.75
7 Female 57 Right 22.5 13.75
8 Female 61 Right 40 38.75
9 Female 34 Right 6.25 0
10 Female 61 Right 8.75 5
11 Female 63 Right 18.75 11.25
12 Female 54 Right 52.5 52.5
13 Male 53 Left 23.75 20
14 Female 58 Left 32.5 32.5
15 Female 48 Left 10 5
16 Male 62 Right 30 30
17 Female 25 Right 3.75 3.75
18 Male 69 Left 31.25 23.75
19 Male 63 Left 15 15
20 Female 66 Left 36.25 33.75
BC, bone conduction; PTA, pure tone average, average of bone 
conduction thresholds for 500, 1,000, 2,000, and 3,000 Hz (12).
Fig. 1. Schematic of the BC Direct function enabling measurement of 
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on a skull simulator. The force level needed to convert to dB HL 
is then subtracted from the maximum output. This gives the 
maximum output value in dBHL that the device can produce.
  If a lower level of stimuli is desired, the digital control values 
in the device are reduced by an equal amount. This can be done 
since a subtraction in the logarithmic domain is the same as a 
division in the linear domain, and hence, the variable control 
value in the device will have no unity. The resulting control val-
ue will be a “relationship” between the maximum output and 
the desired output.
Device control value=-(Maximum output value-Desired stimuli)
Equation 1. Calculation of device control value
The values in dB HL are then converted to digital values in the 
sound processor and produced by the device in dB rel. 1 μN 
(Equation 1). The pure-tone is generated at a set frequency at 
each octave and half-octave between 250-8,000 Hz. The com-
plete system has been verified by the manufacturer (Cochlear 
Bone Anchored Solutions AB, Cochlear Ltd, Gothenburg, Swe-
den) to meet the audiometer standard (ISO 60645-2) with re-
gard to allowable tolerances in terms of level (dB) and frequency 
(Hz). The audiologist can use standard audiological threshold 
seeking techniques to measure the softest response for a given 
frequency and select these values to be used as the basis for the 
hearing loss rather than the standard audiometric test rests.
Procedure
Audiometric evaluation consisting of air and bone conduction 
testing was performed in accordance with ANSI S3.21 in a sound 
insulated test room using a Madsen Conera Audiometer (GN 
Otometrics, Copenhagen, Denmark). For comparison purposes, 
bone conduction thresholds were obtained at 250, 500, 1,000, 
2,000, 3,000, 4,000, and 6,000 Hz with narrow-band noise ap-
plied via air conduction to the contralateral ear when necessary. 
For the measurement of DBC, the Cochlear Baha BP100 sound 
processor was used in conjunction with the Cochlear Baha Fit-
ting Software ver. 1.0. Measurement was conducted using the 
same audiometric techniques as specified in ANSI S3.21 with 
the Baha sound processor microphone turned off. This deter-
mines the softest sound at which the patient can respond 
through DBC. It should not be confused with the measurement 
of an actual ear specific threshold, as masking is not used in this 
measurement.
Determining reference equivalent force threshold
For the reference equivalent force threshold, the starting point 
was the values recommended by Carlsson et al. (10). With the 
BP100 sound processor, it is possible to measure DBC at 6,000 
Hz and provide amplification at 6,000 Hz. Unfortunately, the 
previous study did not measure 6,000 Hz. Based on ISO-389-
3:1994, which shows an increase of 4.5 dB in reference to an 
equivalent threshold force level at 6,000 Hz over 4,000 Hz to 
compensate for the additional skin impedance (13) (i.e., no net 
effect for direct bone conduction), we decided to keep 6,000 Hz 
equivalent to 4,000 Hz. For the pilot study, 11 adult Baha pa-
tients participated. We compared the measured unmasked bone 
conduction measurements with the DBC measurements. For all 
frequencies except 250 Hz and 1,000 Hz, we found that the BC 
and DBC thresholds were within +/-5 dB, which is the accept-
able error rate. In line with a study by van der Pouw et al. (14), 
we decided to correct the values at 250 Hz by 5 dB and at 1,000 
Hz by 6 dB. The extrapolated value at 6,000 Hz showed good 
correspondence with the measured value (Table 2).
RESULTS
Examination of the results led to a number of interesting com-
parisons. First, we compared the measured BC Direct results 
with the measured masked bone conduction responses (Fig. 2). 
Table 2. Comparison of the differences between the published and used values for reference equivalent force threshold for direct bone con-
duction
250 Hz 500 Hz 1,000 Hz 1,500 Hz 2,000 Hz 3,000 Hz 4,000 Hz 6,000 Hz
Carlsson et al. (10)  59.5 48 45.5 34.5 26 28 27.5 28
Initial investigation (measured) 64.95 46.64 36.86 29.05 24.18 26.64 30.68 25.27
Correction  -5.0 0 -6.0 0 0 0 0 0
Final values  54.5 48 39.5 34.5 26 28 27.5 28
Fig. 2. Comparison of the measured masked and unmasked bone 
conduction thresholds versus measured BC Direct responses across 
a group of 20 participants. 
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Masked bone conduction responses were selected for compari-
son, as these are what the audiologist would have readily avail-
able from the audiometric testing and what hearing aid databas-
es, such as Noah, use as the default bone conduction values. 
Therefore, this analysis allows us to compare DBC values with 
standard clinical practice, as recommended by American Speech-
Language-Hearing Association (ASHA) (15).
  Fig. 2 demonstrates that, on average, the measured values were 
consistently 5-10 dB better across the frequency range than the 
patient’s bone conduction thresholds in the test ear. This varia-
tion is outside of the normally accepted audiometric error rate 
of +/-5dB.
  One reason for the difference between measured BC Direct 
and bone conduction thresholds may be due to measurement 
error. To rule this out, we investigated the repeatability of the BC 
Direct procedures and found that across the group, the repeat-
ability (across two separate visits) for BC Direct was within +/-
5dB of the previously measured values. Therefore, BC Direct 
provides a repeatable method of measuring the softest sound 
produced through the Baha sound processor.
  To further understand the performance, we investigated why, 
on average, the BC Direct values might be better than those 
predicted from the pure-tone audiogram. In examining the data, 
there were four groups of participants for whom additional in-
vestigation was required. The first group was comprised of pa-
tients with asymmetrical hearing loss, where the Baha is placed 
on the side with worse sensorineural hearing thresholds. In this 
case, if the patient has sufficiently low interaural attenuation, then 
the non-test cochlea might hear the sound first. Second, for some 
patients, both cochleae may hear the sound at the same time, 
thus allowing loudness summation. Third, for single-sided senso-
rineural deafness, the high variability in interaural attenuation 
might cause difficulties with prediction. Fourth, due to implant 
placement or other anatomical variables, the predicted values 
may differ from actual values (7). 
  Looking at the possible reasons for this difference, one situa-
tion requires further investigation. A number of the possibilities 
include the scenario where the side with the Baha implant may 
have poorer hearing thresholds than the non-Baha side. In this 
situation, even with transcranial attenuation, it is possible that 
the contralateral cochlea could be responding when tested in a 
sound booth. Therefore, the assumption made in a previous study 
(10) that masked and unmasked thresholds can be treated equal-
ly deserves further investigation. In order to investigate this, we 
compared the masked and unmasked bone conduction results 
with the DBC values (Fig. 2).
  The relationship between DBC values and unmasked bone 
conduction results was higher than for masked bone conduction 
results. The DBC and unmasked bone conduction results were 
within 5 dB at all frequencies, except for 250 Hz and 6,000 Hz. 
The differences at 250 Hz are most likely due to vibro-tactile 
difficulties in measuring bone conduction. The differences at 
6,000 Hz are most likely due to calibration issues for transmis-
sion of high frequency tones via a standard bone conductor. 
DISCUSSION
For most patients, the increase in transmission efficiency between 
transcutaneous and percutaneous transmission can be accurately 
estimated using published results (10). For some patients, how-
ever, a number of factors (e.g., significantly better bone conduc-
tion thresholds in the non-Baha ear, use of clinical masking, dif-
ferences in skin thickness or placement of the implant) may re-
sult in the measured DBC to be larger or smaller than predicted. 
Additionally, the data discussed is based on averages, and there 
is between-subjects variability in this study and previous studies 
in terms of DBC values.
  Previous studies (10) have used patients who had the implant 
in the best ear and assumed that there was no need for masking 
and the difference between the BC and DBC thresholds is the 
same with or without masking. Based on their data, the authors 
concluded that either the masked or unmasked information could 
be used. The data from the current study indicates that for some 
patients, the Baha may be placed in the ear with poorer cochlea 
thresholds and that some caution should be taken in assuming 
that unmasked and masked bone conduction thresholds are the 
same. Therefore, to ensure accuracy, the unmasked bone con-
duction thresholds should be used.
  Based on the current study, one could make the argument that 
simply taking the unmasked bone conduction thresholds would 
make redundant the use of tools such as BC Direct. Unfortu-
nately, it is common that in the patient’s chart, only the masked 
values are recorded, because the unmasked values are consid-
ered to be ‘noise.’ Similarly, while the average values are corre-
lated in a manner similar to other areas in audiology, such as the 
measurement of real ear to coupler difference in hearing aid fit-
ting, the individual results contain uncontrolled variability.
  Direct measurement of bone conduction thresholds is recom-
mended for all Baha fittings and especially those cases involving:
- Patients with asymmetrical bone conduction thresholds 
where the Baha is placed in the side with the poorer cochlea 
function.
- Patients with single-sided sensorineural deafness due to the 
variability in interaural attenuation.
- Patients using the soft-band or head-band due to variability 
in transcutaneous transmission (16).
- Patients where the Baha implant was placed in a non-opti-
mum position or with significant craniofacial abnormalities.
  In each of these scenarios, the difference between the actual 
and predicted direct bone conduction thresholds may result in 
the patient being under- or over-amplified and potentially result 
in poorer than predicted performance with the Baha sound pro-
cessor. Given the complexity of correcting the audiogram versus Flynn MC et al.: Measures of Direct Bone Conduction for Baha Fitting    S47
the simplicity and speed of measuring BC Direct, BC Direct 
provides an improved method of compensating for the variabili-
ty in the individual Baha patient.
  From the results obtained in the current study, we can con-
clude that if a patient has better cochlea function in the non-
Baha ear, then this will add into their perception with DBC mea-
surements. However, the clinician may not record unmasked BC 
thresholds in these patients audiometrically but rather record 
only document masked thresholds. Therefore, a fitting using the 
audiometric (masked) thresholds would result in greater gain 
than needed and greater gain than a fitting done with DBC. Giv-
en the complexity of correcting the audiogram versus the sim-
plicity and speed of measuring BC Direct, BC Direct provides 
an improved method for compensating for the variability in the 
individual Baha patient.
  BC Direct provides a validated method of comparing the 
transcutaneous thresholds as measured through audiometry with 
the percutaneous responses from the Baha sound processor. 
These values from BC Direct can then be used in preference to 
the patient’s bone conduction thresholds for the prescription of 
amplification.
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